Join the club for FREE to access the whole archive and other member benefits.

Clinical Trials Arena

Website providing news, insights, and analysis on global clinical trials

Clinical Trials Arena is a leading online platform dedicated to the global clinical trials industry. It serves as a hub for professionals involved in clinical research, providing the latest news, insights, and analysis on clinical trials, drug development, and regulatory trends. The platform covers a wide array of therapeutic areas, focusing on innovations and challenges in the field, including patient recruitment, trial design, data management, and new methodologies.

In addition to news and expert commentary, Clinical Trials Arena features in-depth articles, interviews with industry leaders, and case studies showcasing advancements in clinical trial practices. It also explores the intersection of technology and clinical research, such as the use of AI, decentralized trials, and digital biomarkers. By offering comprehensive content tailored to pharmaceutical companies, CROs, and clinical research professionals, Clinical Trials Arena plays a crucial role in fostering informed decision-making and collaboration across the industry.

Visit website: https://www.clinicaltrialsarena.com/

 clinical-trials-arena

 TrialsArena

Details last updated 22-Nov-2024

People at Clinical Trials Arena

Ross Law

Reporter at Clinical Trials Arena

Urte Fultinaviciute

Healthcare reporter for Clinical Trials Arena

Articles sourced from Clinical Trials Arena

MDI Therapeutics advances new treatment for SSc-ILD

MDI Therapeutics advances new treatment for SSc-ILD

Clinical Trials Arena - 11-Jun-2024

Early-stage trial explores a novel approach to tackling fibrosis and inflammation

Curasen readies Alzheimer's drug CST-3056 for 2024 clinical trial

Curasen readies Alzheimer's drug CST-3056 for 2024 clinical trial

Clinical Trials Arena - 18-Oct-2023

CST-3056 targets cognitive decline in Alzheimer’s with a phase I trial in 2024

Tranquis Therapeutics concludes Phase I trial of a drug targeting ALS

Tranquis Therapeutics concludes Phase I trial of a drug targeting ALS

Clinical Trials Arena - 03-Jun-2022

The drug demonstrated potential in treating neurodegenerative diseases